MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA178613
National Institutes of Health
Grant: R01 DE027749
U.S. Department of Defense
Grant: W81XWH-19-1-0090
National Institutes of Health
Grant: 5R01DE027749-05
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
National Institutes of Health
Grant: 4R01CA178613-04
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
NIDDK NIH HHS
Grant: T32 DK101003
NCI NIH HHS
Grant: U54 CA217450
FWCI
0.30
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals